Matches in SemOpenAlex for { <https://semopenalex.org/work/W2037756952> ?p ?o ?g. }
- W2037756952 endingPage "1977" @default.
- W2037756952 startingPage "1972" @default.
- W2037756952 abstract "Both irinotecan (CPT-11) and S-1 are active against colorectal cancer; however, as S-1 is a prodrug of 5-fluorouracil (5-FU), 5-FU and its metabolites might inhibit the antitumour effect of CPT-11. Therefore, we designed a sequential combination, in which CPT-11 infusion was given on day 1 and S-1 was given orally at 80 mg m−2 per day on days 3–16 every 3 weeks. Twelve patients entered the phase I study, and the recommended doses were determined as a CPT-11 dose of 150 mg m−2 and an S-1 dose of 80 mg m−2. In all, 36 patients entered the phase II study, of whom 4 and 16 had complete and partial responses. The overall response rate was 55.6% (95% confidence interval, 38.1–72.1%), and median progression-free survival was 7.7 months (95% confidence interval, 4.8–12.6 months). Grade 3 neutropenia was the most common haematological toxicity and occurred in 6.5% of 215 treatment courses. Grade 3 non-haematological toxicities included anorexia (1.4%) and diarrhoea (0.9%). There was no grade 4 toxicity of any kind. Our results suggest that this regimen is convenient, safe and promising, compared with conventional regimens for patients with metastatic colorectal cancer." @default.
- W2037756952 created "2016-06-24" @default.
- W2037756952 creator A5000941260 @default.
- W2037756952 creator A5000947818 @default.
- W2037756952 creator A5004342375 @default.
- W2037756952 creator A5005976072 @default.
- W2037756952 creator A5023481395 @default.
- W2037756952 creator A5032855161 @default.
- W2037756952 creator A5047801629 @default.
- W2037756952 creator A5064504927 @default.
- W2037756952 creator A5067063901 @default.
- W2037756952 creator A5069433827 @default.
- W2037756952 creator A5073041790 @default.
- W2037756952 creator A5075294352 @default.
- W2037756952 date "2009-11-17" @default.
- W2037756952 modified "2023-10-17" @default.
- W2037756952 title "Phase I/II study of sequential therapy with irinotecan and S-1 for metastatic colorectal cancer" @default.
- W2037756952 cites W1499419719 @default.
- W2037756952 cites W181158363 @default.
- W2037756952 cites W1928747779 @default.
- W2037756952 cites W1965809073 @default.
- W2037756952 cites W2035829068 @default.
- W2037756952 cites W2040401100 @default.
- W2037756952 cites W2049929214 @default.
- W2037756952 cites W2053512619 @default.
- W2037756952 cites W2065064849 @default.
- W2037756952 cites W2070321906 @default.
- W2037756952 cites W2077902459 @default.
- W2037756952 cites W2102172908 @default.
- W2037756952 cites W2109603003 @default.
- W2037756952 cites W2121368761 @default.
- W2037756952 cites W2128447158 @default.
- W2037756952 cites W2134617967 @default.
- W2037756952 cites W2139248078 @default.
- W2037756952 cites W2142564546 @default.
- W2037756952 cites W2157769714 @default.
- W2037756952 cites W2263132210 @default.
- W2037756952 cites W2314927739 @default.
- W2037756952 cites W2332894026 @default.
- W2037756952 cites W4231262656 @default.
- W2037756952 doi "https://doi.org/10.1038/sj.bjc.6605432" @default.
- W2037756952 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2795445" @default.
- W2037756952 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19920821" @default.
- W2037756952 hasPublicationYear "2009" @default.
- W2037756952 type Work @default.
- W2037756952 sameAs 2037756952 @default.
- W2037756952 citedByCount "18" @default.
- W2037756952 countsByYear W20377569522012 @default.
- W2037756952 countsByYear W20377569522013 @default.
- W2037756952 countsByYear W20377569522015 @default.
- W2037756952 countsByYear W20377569522016 @default.
- W2037756952 countsByYear W20377569522019 @default.
- W2037756952 countsByYear W20377569522021 @default.
- W2037756952 countsByYear W20377569522022 @default.
- W2037756952 crossrefType "journal-article" @default.
- W2037756952 hasAuthorship W2037756952A5000941260 @default.
- W2037756952 hasAuthorship W2037756952A5000947818 @default.
- W2037756952 hasAuthorship W2037756952A5004342375 @default.
- W2037756952 hasAuthorship W2037756952A5005976072 @default.
- W2037756952 hasAuthorship W2037756952A5023481395 @default.
- W2037756952 hasAuthorship W2037756952A5032855161 @default.
- W2037756952 hasAuthorship W2037756952A5047801629 @default.
- W2037756952 hasAuthorship W2037756952A5064504927 @default.
- W2037756952 hasAuthorship W2037756952A5067063901 @default.
- W2037756952 hasAuthorship W2037756952A5069433827 @default.
- W2037756952 hasAuthorship W2037756952A5073041790 @default.
- W2037756952 hasAuthorship W2037756952A5075294352 @default.
- W2037756952 hasBestOaLocation W20377569521 @default.
- W2037756952 hasConcept C121608353 @default.
- W2037756952 hasConcept C126322002 @default.
- W2037756952 hasConcept C141071460 @default.
- W2037756952 hasConcept C143998085 @default.
- W2037756952 hasConcept C2776694085 @default.
- W2037756952 hasConcept C2777063308 @default.
- W2037756952 hasConcept C2780259306 @default.
- W2037756952 hasConcept C2780456651 @default.
- W2037756952 hasConcept C2781413609 @default.
- W2037756952 hasConcept C29730261 @default.
- W2037756952 hasConcept C31760486 @default.
- W2037756952 hasConcept C44249647 @default.
- W2037756952 hasConcept C526805850 @default.
- W2037756952 hasConcept C71924100 @default.
- W2037756952 hasConcept C90924648 @default.
- W2037756952 hasConceptScore W2037756952C121608353 @default.
- W2037756952 hasConceptScore W2037756952C126322002 @default.
- W2037756952 hasConceptScore W2037756952C141071460 @default.
- W2037756952 hasConceptScore W2037756952C143998085 @default.
- W2037756952 hasConceptScore W2037756952C2776694085 @default.
- W2037756952 hasConceptScore W2037756952C2777063308 @default.
- W2037756952 hasConceptScore W2037756952C2780259306 @default.
- W2037756952 hasConceptScore W2037756952C2780456651 @default.
- W2037756952 hasConceptScore W2037756952C2781413609 @default.
- W2037756952 hasConceptScore W2037756952C29730261 @default.
- W2037756952 hasConceptScore W2037756952C31760486 @default.
- W2037756952 hasConceptScore W2037756952C44249647 @default.
- W2037756952 hasConceptScore W2037756952C526805850 @default.
- W2037756952 hasConceptScore W2037756952C71924100 @default.
- W2037756952 hasConceptScore W2037756952C90924648 @default.